Stanford Cancer Institute Clinical Trials Office Blog

News & Updates from the SCI-CTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • SCI Clinical Trials Office
  • Stanford Cancer Institute

Investigational Product Return Documentation Update

May 30, 2023 - SCI Communications

The process for documenting investigational product accountability (ie pills/pill bottles) has been updated. Effective 6/2/23, you will no longer provide IDS with a copy of the “Investigational Product Return” form when returning IP to IDS. You will instead use the updated Investigational Product Custody Smartphrase Template to document participant training, chain of custody and drug accountability.

The updated document can be found  in Coordinator Corner:

  • On Study > Investigational Pharmacy and Investigational Product > Investigational Product Custody Smartphrase Template (Form/Logs) – May 18, 2023

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • PRISM
  • PRMS
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube